Fulminant Tumour Lysis Syndrome after Nivolumab and Ipilimumab treatment for Hepatocellular Carcinoma. Kwok GW, Wing Fung TH, Yau T. J Hepatol 2025 Jul 9:S0168-8278(25)02331-1. doi: 10.1016/j.jhep.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kwok GW, Wing Fung TH, Yau T. Fulminant Tumour Lysis Syndrome after Nivolumab and Ipilimumab treatment for Hepatocellular Carcinoma. J Hepatol 2025 Jul 9:S0168-8278(25)02331-1. doi: 10.1016/j.jhep.2025.
PMID: 40645593